You just read:

Medimetriks announces the results of a successful Phase 2 trial of MM36 in Atopic Dermatitis; Study results and design published in the Journal of the American Academy of Dermatology (JAAD)

News provided by

Medimetriks Pharmaceuticals, Inc.

23 May, 2016, 08:36 ET